[2-(2,5-difluorophenyl)-2-oxoethyl] 3-methoxy-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate
C19H25F2NO6 — CID 90457800
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-(2,5-difluorophenyl)-2-oxoethyl] 3-methoxy-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate
[2-(2,5-difluorophenyl)-2-oxoethyl] 3-methoxy-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate (PubChem CID 90457800) has the molecular formula C19H25F2NO6 and a molecular weight of 401.41 g/mol. Its IUPAC name is [2-(2,5-difluorophenyl)-2-oxoethyl] 3-methoxy-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate.
Molecular Properties
| Compound Name | [2-(2,5-difluorophenyl)-2-oxoethyl] 3-methoxy-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate |
|---|---|
| PubChem CID | 90457800 |
| Molecular Formula | C19H25F2NO6 |
| Molecular Weight | 401.41 g/mol |
| Exact Mass | 401.16 |
| IUPAC Name | [2-(2,5-difluorophenyl)-2-oxoethyl] 3-methoxy-3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate |
| SMILES | COC(C)(C)C(NC(=O)OC(C)(C)C)C(=O)OCC(=O)c1cc(F)ccc1F |
| InChI | InChI=1S/C19H25F2NO6/c1-18(2,3)28-17(25)22-15(19(4,5)26-6)16(24)27-10-14(23)12-9-11(20)7-8-13(12)21/h7-9,15H,10H2,1-6H3,(H,22,25) |
| InChIKey | KLPGGWGPBXHPGR-UHFFFAOYSA-N |
| XLogP | 3.01 |
| TPSA | 90.93 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 401.41 |
| LogP ≤ 5 | 3.01 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90457800 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.